[go: up one dir, main page]

NO20034139L - Faste oralt dispergerbare farmasöytiske formuleringer - Google Patents

Faste oralt dispergerbare farmasöytiske formuleringer

Info

Publication number
NO20034139L
NO20034139L NO20034139A NO20034139A NO20034139L NO 20034139 L NO20034139 L NO 20034139L NO 20034139 A NO20034139 A NO 20034139A NO 20034139 A NO20034139 A NO 20034139A NO 20034139 L NO20034139 L NO 20034139L
Authority
NO
Norway
Prior art keywords
pharmaceutical formulations
solid orally
orally dispersible
dispersible pharmaceutical
solid
Prior art date
Application number
NO20034139A
Other languages
English (en)
Other versions
NO326259B1 (no
NO20034139D0 (no
Inventor
Michel Serpelloni
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of NO20034139D0 publication Critical patent/NO20034139D0/no
Publication of NO20034139L publication Critical patent/NO20034139L/no
Publication of NO326259B1 publication Critical patent/NO326259B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20034139A 2002-01-18 2003-09-17 Faste oralt-dispergerbare farmasoytiske formuleringer NO326259B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200647A FR2834889B1 (fr) 2002-01-18 2002-01-18 Forme pharmaceutique solide orodispersible
PCT/FR2002/004454 WO2003061623A1 (fr) 2002-01-18 2002-12-19 Forme pharmaceutique solide orodispersible

Publications (3)

Publication Number Publication Date
NO20034139D0 NO20034139D0 (no) 2003-09-17
NO20034139L true NO20034139L (no) 2003-11-11
NO326259B1 NO326259B1 (no) 2008-10-27

Family

ID=27589521

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034139A NO326259B1 (no) 2002-01-18 2003-09-17 Faste oralt-dispergerbare farmasoytiske formuleringer

Country Status (22)

Country Link
US (1) US7201922B2 (no)
EP (1) EP1465593B1 (no)
JP (1) JP2005515240A (no)
KR (1) KR100961367B1 (no)
CN (1) CN1248681C (no)
AT (1) ATE439828T1 (no)
AU (1) AU2002364468C1 (no)
BR (1) BR0208161A (no)
CA (1) CA2441796A1 (no)
CZ (1) CZ20032486A3 (no)
DE (1) DE60233436D1 (no)
FR (1) FR2834889B1 (no)
HU (1) HUP0303948A2 (no)
IL (2) IL158691A0 (no)
MX (1) MXPA03008420A (no)
NO (1) NO326259B1 (no)
NZ (1) NZ529694A (no)
PL (1) PL209144B1 (no)
RU (1) RU2317812C2 (no)
SK (1) SK287812B6 (no)
WO (1) WO2003061623A1 (no)
ZA (1) ZA200308664B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
WO2000024380A1 (en) * 1998-10-27 2000-05-04 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
FR2834894B1 (fr) * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
DE10229472A1 (de) * 2002-07-01 2004-01-15 Symrise Gmbh & Co. Kg Kompaktierter Milchsäurementhylester
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
KR101109633B1 (ko) 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
FR2920311B1 (fr) * 2007-08-31 2010-06-18 Galenix Innovations Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
ES2758624T3 (es) * 2009-02-12 2020-05-06 Fuji Chem Ind Co Ltd Composición de partículas desintegrantes y material de desintegración rápida moldeado por compresión que comprende la misma
RU2497505C1 (ru) * 2012-11-07 2013-11-10 Максим Эдуардович Запольский Новая лекарственная композиция для лечения болевого синдрома при спазме гладкой мускулатуры
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства
WO2015008825A1 (ja) * 2013-07-19 2015-01-22 株式会社三和化学研究所 口腔内崩壊錠
DE102017103346A1 (de) 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
JP7138666B2 (ja) * 2018-01-24 2022-09-16 大原薬品工業株式会社 γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
EP0922464B1 (en) * 1996-07-12 2005-03-30 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
FR2752162B1 (fr) 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
AU3574500A (en) 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.
CA2426682C (en) * 2000-10-16 2010-02-16 Daiichi Pharmaceutical Co., Ltd. Intraoral rapid-disintegrating medicinal compositions and production process thereof
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
WO2003053416A1 (en) * 2001-12-21 2003-07-03 Pfizer Products Inc. Directly compressible formulations of azithromycin
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
CA2479735C (en) * 2002-03-20 2011-05-17 Elan Pharma International Ltd. Fast dissolving dosage forms having reduced friability

Also Published As

Publication number Publication date
NZ529694A (en) 2006-04-28
JP2005515240A (ja) 2005-05-26
WO2003061623A1 (fr) 2003-07-31
KR100961367B1 (ko) 2010-06-07
ATE439828T1 (de) 2009-09-15
KR20040073288A (ko) 2004-08-19
HUP0303948A2 (hu) 2004-04-28
SK11712003A3 (sk) 2004-02-03
US20030147947A1 (en) 2003-08-07
PL209144B1 (pl) 2011-07-29
SK287812B6 (sk) 2011-10-04
CZ20032486A3 (cs) 2004-01-14
NO326259B1 (no) 2008-10-27
AU2002364468C1 (en) 2009-01-22
CN1248681C (zh) 2006-04-05
US7201922B2 (en) 2007-04-10
DE60233436D1 (de) 2009-10-01
RU2317812C2 (ru) 2008-02-27
EP1465593A1 (fr) 2004-10-13
FR2834889B1 (fr) 2004-04-02
IL158691A (en) 2008-08-07
HU0303948D0 (en) 2004-01-28
CN1516576A (zh) 2004-07-28
NO20034139D0 (no) 2003-09-17
MXPA03008420A (es) 2004-03-16
RU2003128025A (ru) 2005-03-27
PL362762A1 (en) 2004-11-02
AU2002364468B2 (en) 2008-06-26
ZA200308664B (en) 2004-11-08
IL158691A0 (en) 2004-05-12
FR2834889A1 (fr) 2003-07-25
EP1465593B1 (fr) 2009-08-19
BR0208161A (pt) 2004-03-02
CA2441796A1 (fr) 2003-07-31

Similar Documents

Publication Publication Date Title
NO20034139L (no) Faste oralt dispergerbare farmasöytiske formuleringer
DK1198233T3 (da) Sulfonamid- og sulfamidsubstituerede imidazoquinoliner
DK1545467T3 (da) Faste farmaceutiske formuleringer omfattende telmisartan
EE200100670A (et) Amiidasendatud imidasokinoliinid
CY2014001I1 (el) Συνδυασμος αζελαστινης και φλουτικαζονης
TW200514784A (en) Sulfonamide substituted imidazoquinolines
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
MEP18208A (en) Immune response modifier foam formulations
NO20030397D0 (no) Amyloid målsökende billeddannende midler og anvendelser av samme
CO5590918A2 (es) Formulaciones
IL173112A0 (en) Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
DE602004006860D1 (de) Capsaicinoid enthaltende pharmazeutische zusammensetzung zur oralen verabreichung
DK1330258T3 (da) Kahalalid F-formulering
HUP0401854A2 (hu) COX-2 inhibitorokat és aszpirint tartalmazó kombinációk
TW200733954A (en) Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
DK1608344T3 (da) Orale cladribin-formuleringer
WO2005030142A8 (en) Rifalazil formulations
CY1113164T1 (el) Στοματικως αποσαθρουμενη κονις περιλαμβανουσα κιλοσταζολη και μαννιτολη
HUP0302738A2 (hu) SARP-1 alkalmazása scleroderma kezelésére és megelőzésére
DK1273301T3 (da) Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration
MXPA03008975A (es) Estabilizacion y esterilizacion terminal de formulaciones de fosfolipidos.
DE602004009931D1 (de) An der wachstumsfördernden funktion des essigsäurebakteriums beteiligtes gen und verwendungen davon
DE602004032530D1 (de) Rdauungsfunktion
DE50307521D1 (de) Arzneimittel zur behandlung des "systemic inflammatory response syndrome"
ITRM20020592A1 (it) Procedimento e formulazioni per la preparazione di

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees